Department of Trauma Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Department of Orthopaedic Sports Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
BMC Musculoskelet Disord. 2021 Oct 27;22(1):905. doi: 10.1186/s12891-021-04775-8.
Treatment of medial clavicle fractures is still controversially discussed in the community of upper extremity surgeons. An increasing number of symptomatic non-unions following conservative treatment of displaced fractures led to the development of various surgical approaches. Aim of this study was to evaluate the clinical and radiological outcome following operative treatment of displaced medial end clavicle fractures.
Patients who presented with a displaced fracture of the medial clavicle between September 2012 and December 2019 were retrospectively enrolled in this study. All patients were operatively treated with open reduction and internal fixation (ORIF) using an anatomically precontoured locking compression plate (LCP) originally designed for the lateral clavicle (Synthes®, Umkirch, Germany). Functional outcome was recorded using the American Shoulder and Elbow Surgeons (ASES) Score, the Munich Shoulder Questionnaire (MSQ), Shoulder Pain and Disability Index (SPADI) and Constant Score.
Overall 18 patients with a mean age of 54.5 ± 23.5 years suffering from a displaced fracture of the medial clavicle were identified. The mean follow-up was 40.9 ± 26.2 months. The mean ASES accounted for 88.3 ± 20.8 points, the mean MSQ was 83.1 ± 21.7 points, the mean SPADI was 85.6 ± 22.5 and a mean normative age- and sex-specific Constant Score of 77.5 ± 19.1 points resulted. No minor or major complications were observed. Radiologic fracture consolidation was achieved in all patients after a mean of 6.4 months.
Surgical treatment of displaced medial clavicle fractures using an anatomically precontoured locking plate originally designed for the lateral clavicle led to very good to excellent clinical and functional results.
No: DRKS00024813 , retrospectively registered 19.03.2021 ( www.drks.de ).
在上肢外科医生群体中，对于锁骨内侧骨折的治疗仍存在争议。越来越多的保守治疗移位骨折后出现症状性骨不连，导致各种手术入路的发展。本研究旨在评估手术治疗移位锁骨内侧端骨折的临床和影像学结果。
回顾性纳入 2012 年 9 月至 2019 年 12 月期间患有移位性锁骨内侧骨折的患者。所有患者均采用解剖预成型锁定加压钢板（LCP）进行切开复位内固定（ORIF）治疗，该钢板最初设计用于治疗外侧锁骨（Synthes®, Umkirch, Germany）。采用美国肩肘外科医师（ASES）评分、慕尼黑肩部问卷（MSQ）、肩部疼痛和残疾指数（SPADI）和 Constant 评分记录功能结果。
共纳入 18 例平均年龄 54.5±23.5 岁的移位性锁骨内侧骨折患者。平均随访时间为 40.9±26.2 个月。平均 ASES 评分为 88.3±20.8 分，平均 MSQ 评分为 83.1±21.7 分，平均 SPADI 评分为 85.6±22.5 分，平均符合年龄和性别特定的 Constant 评分为 77.5±19.1 分。未观察到轻微或严重并发症。所有患者在平均 6.4 个月后均实现了骨折愈合。
采用解剖预成型锁定钢板治疗移位性锁骨内侧骨折，该钢板最初设计用于治疗外侧锁骨，可获得非常好至优秀的临床和功能结果。
无：DRKS00024813，于 2021 年 3 月 19 日（www.drks.de）进行回顾性注册。
